In a falling market one of the day's divers is health care group Ultrasis.
The business has plunged 71% to just 0.185p after the company said it planned to cancel its Aim listing at the behest of a major shareholder, Paul Bell.
Ultrasis had agreed loan facilities with Bell and was allowed to draw up to £1m in any rolling twelve month period.
Now it says it has reached that limit, and while Bell has agreed to provide further funds above £1m, that is subject to a review of its short and medium term working capital requirements and, crucially, the company seeking to cancel its Aim listing.
